Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 3, 2025 22:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · derivative · entry 6 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,418 Underlying: Common stock · 10,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 4,426 | $2.14 | $9,471.64 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 4 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464,522 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 3 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · derivative · entry 6 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,517 Underlying: Common stock · 3,516 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,786 | $2.14 | $3,822.04 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 4 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,744 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,348 Underlying: Common stock · 5,469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 2,467 | $2.23 | $5,501.41 |
DisclosureSEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,859 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118167 · tm2532666-1_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · derivative · entry 5 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,949 Underlying: Common stock · 8,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 4,464 | $2.23 | $9,954.72 |
DisclosureSEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,734 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118170 · tm2532666-4_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 41,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · derivative · entry 5 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,344 Underlying: Common stock · 41,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 17,701 | $2.23 | $39,473.23 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,531 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 41,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118168 · tm2532666-2_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 476,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · derivative · entry 5 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,949 Underlying: Common stock · 8,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 4,464 | $2.23 | $9,954.72 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,014 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-118169 · tm2532666-3_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,817 Underlying: Common stock · 5,470 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 2,467 | $2.19 | $5,402.73 |
DisclosureSEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,857 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087547 · tm2525186-3_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · derivative · entry 4 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,738 Underlying: Common stock · 8,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,813 Underlying: Common stock · 3,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 6,448 | $2.19 | $14,121.12 |
DisclosureSEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,409 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 12,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087546 · tm2525186-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:35 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 41,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · derivative · entry 4 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,013 Underlying: Common stock · 41,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:35 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,385 Underlying: Common stock · 10,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:35 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 22,127 | $2.19 | $48,458.13 |
DisclosureSEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,563 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:35 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 52,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087549 · tm2525186-4_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 456,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · derivative · entry 4 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,738 Underlying: Common stock · 8,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,033 Underlying: Common stock · 3,516 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 6,250 | $2.19 | $13,687.50 |
DisclosureSEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,689 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:30 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 12,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087545 · tm2525186-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:06 UTC |
Roche Corleen M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075687 · tm2522878-2_4seq1.xml · derivative · entry 2 Roche Corleen M. · CIK 0001857905 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F1 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:06 UTC |
Roche Corleen M.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001104659-25-075687 · tm2522878-2_4seq1.xml · derivative · entry 1 Roche Corleen M. · CIK 0001857905 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common stock · 300,000 shares Expires 2035-08-06 F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:05 UTC |
YARNO WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 67,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060245 · tm2518181-1_4seq1.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,546 Underlying: Common Stock · 67,546 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:09 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 67,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060254 · tm2518181-5_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,546 Underlying: Common Stock · 67,546 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:08 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 67,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060253 · tm2518181-4_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,546 Underlying: Common Stock · 67,546 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:07 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 67,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060251 · tm2518181-3_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,546 Underlying: Common Stock · 67,546 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:06 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 135,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-060249 · tm2518181-2_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,092 Underlying: Common Stock · 135,092 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:05 UTC |
Kirby Daniel GordonChief Commercial Officer
|
PurchaseCommon Stock | 30,000 | $1.84 | $55,200.00 |
DisclosureSEC source: 0001104659-25-057310 · tm2517335-1_4seq1.xml · nonDerivative · entry 1 Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:51 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,287 Underlying: Common Stock · 5,469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:51 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 2,467 | $1.76 | $4,341.92 |
DisclosureSEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,854 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:51 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056444 · tm2517077-5_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · derivative · entry 4 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,528 Underlying: Common stock · 8,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,720 Underlying: Common stock · 3,906 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 6,448 | $1.76 | $11,348.48 |
DisclosureSEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,160 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 12,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056438 · tm2517077-3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:50 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 41,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056440 · tm2517077-4_4seq1.xml · derivative · entry 4 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,682 Underlying: Common stock · 41,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F7 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.